Zhang Yuxun, Bharathi Sivakama S, Rardin Matthew J, Lu Jie, Maringer Katherine V, Sims-Lucas Sunder, Prochownik Edward V, Gibson Bradford W, Goetzman Eric S
From the Department of Pediatrics, University of Pittsburgh School of Medicine, University of Pittsburgh, Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15224 and.
Buck Institute for Research on Aging, Novato, California 94945.
J Biol Chem. 2017 Jun 16;292(24):10239-10249. doi: 10.1074/jbc.M117.785022. Epub 2017 Apr 30.
SIRT5 is a lysine desuccinylase known to regulate mitochondrial fatty acid oxidation and the urea cycle. Here, SIRT5 was observed to bind to cardiolipin via an amphipathic helix on its N terminus. , succinyl-CoA was used to succinylate liver mitochondrial membrane proteins. SIRT5 largely reversed the succinyl-CoA-driven lysine succinylation. Quantitative mass spectrometry of SIRT5-treated membrane proteins pointed to the electron transport chain, particularly Complex I, as being highly targeted for desuccinylation by SIRT5. Correspondingly, SIRT5 HEK293 cells showed defects in both Complex I- and Complex II-driven respiration. In mouse liver, SIRT5 expression was observed to localize strictly to the periportal hepatocytes. However, homogenates prepared from whole SIRT5 liver did show reduced Complex II-driven respiration. The enzymatic activities of Complex II and ATP synthase were also significantly reduced. Three-dimensional modeling of Complex II suggested that several SIRT5-targeted lysine residues lie at the protein-lipid interface of succinate dehydrogenase subunit B. We postulate that succinylation at these sites may disrupt Complex II subunit-subunit interactions and electron transfer. Lastly, SIRT5 mice, like humans with Complex II deficiency, were found to have mild lactic acidosis. Our findings suggest that SIRT5 is targeted to protein complexes on the inner mitochondrial membrane via affinity for cardiolipin to promote respiratory chain function.
SIRT5是一种赖氨酸去琥珀酰化酶,已知其可调节线粒体脂肪酸氧化和尿素循环。在此研究中,发现SIRT5通过其N端的两亲性螺旋与心磷脂结合。使用琥珀酰辅酶A对肝脏线粒体膜蛋白进行琥珀酰化修饰。SIRT5在很大程度上逆转了由琥珀酰辅酶A驱动的赖氨酸琥珀酰化。对经SIRT5处理的膜蛋白进行定量质谱分析表明,电子传递链,尤其是复合体I,是SIRT5去琥珀酰化的高度靶向对象。相应地,SIRT5基因敲除的HEK293细胞在复合体I和复合体II驱动的呼吸作用中均表现出缺陷。在小鼠肝脏中,观察到SIRT5的表达严格定位于门静脉周围的肝细胞。然而,从整个SIRT5基因敲除小鼠肝脏制备的匀浆确实显示复合体II驱动的呼吸作用减弱。复合体II和ATP合酶的酶活性也显著降低。复合体II的三维模型表明,几个被SIRT5靶向的赖氨酸残基位于琥珀酸脱氢酶亚基B的蛋白质-脂质界面处。我们推测这些位点的琥珀酰化可能会破坏复合体II亚基之间的相互作用和电子传递。最后,发现SIRT5基因敲除小鼠与患有复合体II缺乏症的人类一样,存在轻度乳酸酸中毒。我们的研究结果表明,SIRT5通过对心磷脂的亲和力靶向线粒体内膜上的蛋白质复合物,以促进呼吸链功能。